necessary for the progression of colorectal tumors. A global The Apc1638N mouse carries a targeted mutant allele at DNA hypomethylation is found in early tumor stages, whereas the endogenous adenomatous polyposis coli (Apc) gene and mutations of the K-ras oncogene occur in~50% of the early represents a unique in vivo model to study intestinal tumor to intermediate types of adenomas. More advanced stages of formation and progression. Heterozygous Apc ⍣ /Apc1638N intestinal tumors are characterized by mutations in the DCC mice progressively develop 5-6 adenomas and adeno-(deleted in colorectal cancer) and TP53 tumor suppressor genes carcinomas of the small intestine within the first 6 months in respectively 70% and 75% of the cases (7) . of life following a histologic sequence similar to that Several mouse models for intestinal tumorigenesis have observed in human intestinal tumors. Here, we present the been generated by introducing specific mutations into the somatic mutation analysis of a total of 57 tumors. The murine Apc gene. A severe phenotype is observed in mice results indicate that in ജ75% of the lesions tested the wild heterozygous for the Min (multiple intestinal neoplasia) and type copy of the Apc gene is lost and that this LOH event Apc ∆716 mutation, characterized by truncated Apc polypeptides extends to the entire mouse chromosome 18. Unexpectedly, of 95 and 80 kDa respectively (8) (9) (10) . These mutations, when mutations at the K-, N-and H-ras genes have not been present on an inbred C57BL/6J background, result in~100 found in these tumors. Immunohistochemical analysis of (Min) and 200-500 (Apc ∆716 ) adenomas throughout the entire the Apc1638N tumors failed to detect accumulation of the intestinal tract, the great majority of which have lost the Tp53 protein. Also, no mutations have been found in exons remaining wild type copy of Apc (10) (11) (12) (13) . In the Min mouse, 7 and 8 of the Tp53 gene. These results indicate that, this Apc allelic loss extends to the entire chromosome 18 (11) although the genetic inactivation of Apc is involved in the where other putative tumor suppressor genes, i.e. Dcc, Mcc initiating event of the human as well as murine intestinal and α-catenin, are also localized (14) (15) (16) . These results show tumorigenesis, tumor growth and progression follow differthat, as for most human adenomas, mutation of both Apc ent mutational pathways in these two species.
copies is required for intestinal tumor formation in mouse. However, whether progression of these adenomas towards malignancy is associated with mutation of the K-ras and Tp53 Introduction genes, as observed in human colorectal tumors, has not been Several genes have been found to be implicated in the reported yet. progression from a normal human intestinal cell to a malignant Here, we report the analysis of 42 adenomas and 15 adenocarcinoma. One of the earliest events in this pathway adenocarcinomas, all resected from the intestine of Apc1638N appears to be the mutation of the adenomatous polyposis coli mice, for the presence of mutations in the Apc, H-ras, K-ras, (APC*) gene. This gene encodes for a 312 kDa (2843 aa) N-ras and Tp53 genes. The Apc1638N mouse model was protein with unknown function, although its association with generated by gene targeting via embryonic stem cells by catenins suggests a role in the regulation of cell adhesion introducing a neomycin expression cassette at codon 1638 of and in the intracellular transmission of adhesion signals (1).
the endogenous Apc gene. This results in a frameshift predicted Germline mutations at this gene lead to familial adenomatous to lead to a truncated Apc polypeptide of~185 kDa (17 in mouse.
Assessment of allelic imbalance
Amplified fragments were resolved in a denaturing 6% polyacrylamide gel,
Materials and methods
dried on paper and the number of counts per allele were determined on a Animals, tumor samples and histopathological classification phosphor imager. Subsequently, the number of counts of the larger allele was divided by the counts of the smaller allele to obtain an allelic ratio. A mean All the C57BL/6JIco-Apc1638N (here referred to as B6-Apc1638N) animals allelic ratio was calculated for at least eight normal controls. This value was employed in this study were derived by backcrossing the original B6 ϫ 129/ used to generate a comparative ratio (CR) Ͼ1.0 by dividing the tumor allelic Ola-Apc1638N to C57BL/6J for 7-8 generations.
ratio by the mean normal allelic ratio (21) . In this way, normalization of To obtain intestinal tumor material, heterozygous Apc1638N mice were allelic imbalances already observed in wild type controls due to preferential killed at 8-16 months by euthanization with halothane, after which the entire amplification of a specific allele, is not necessary. A CR Ͼ1.5 was interpreted intestine was removed and opened longitudinally. Sections of~10 cm were as significant, i.e. indicative of loss of the wild type allele. spread out flat on filter paper and fixed overnight at 4°C in Notox ® (Earth Safe Industries, Inc., Bellemead, NJ). Tumors were resected, transferred to H-, K-and N-ras mutation analysis 70% ethanol and embedded in paraffin.
To detect mutations in the H-, K-and N-ras genes, exons 1 and 2 of each In total, 57 tumors were dissected from heterozygous Apc ϩ /Apc1638N mice gene were amplified, dot-blotted on nylon membranes and hybridized with on two different genetic backgrounds: 35 directly from B6-Apc1638N and 22
allele-specific oligonucleotides (ASO), recognizing all possible activating from F1[C3H/HeOuJIco ϫ C57BL/6JIco-Apc1638N] (here referred to as substitutions at codons 12, 13 and 61. All exons were amplified in two PCR C3HxB6-Apc1638N). Localization of the B6-Apc1638N tumors was as follows:
rounds with primers described elsewhere (22) . PCR conditions were essentially 22 in the periampullary region, eight elsewhere in the duodenum, two in the as described for the Apc LOH analysis except for 0.2 mM of each dNTP, jejunum, and three in the ileum. Of the 22 C3HxB6-Apc1638N tumors, six 3 mM MgCl 2 , 1 U Taq polymerase and 10 pmol of each primer in a total were localized in the periampullary region, another six elsewhere in the volume of 50 µl. After an initial denaturation of 5 min at 94°C, each round duodenum and 10 in the jejunum. Histopathological analysis of the tumors of amplification consisted of 30 cycles at 94°C for 60 s, 55°C for 90 s and was performed using standard criteria for the classification of adenomas and 72°C for 120 s. Two microliters of the initial PCR were re-amplified with the the assessment of the degree of dysplasia (18) . The diagnosis of adenosame primer pair. Subsequently,~100 ng of PCR-product was denatured in carcinoma was made when glandular structures with severely abnormal shapes 0.2 N NaOH and dot-blotted on nylon membrane. Each replicate filter and atypical epithelial cells, or small groups of epithelial cells, were obviously contained a positive control for the ASO, obtained by a second PCR round surrounded by stroma showing a desmoplastic response. In many cases on the wild-type amplification products with the respective ASO and an invasion of muscle was seen. In some cases these abnormalities were seen opposing exon primer. ASO's used for hybridization, were either 5Ј-end within polyps and invasion of muscle was not seen. These cases were classified labeled with [γ-32 P]ATP or 3Ј-end labeled with digoxigenin-ddUTP according as adenocarcinomas; it is possible that some of these cases represented to the manufacturer's instructions (Boehringer Mannheim, Mannheim, Gerintramucosal carcinomas (19) . Of the 57 lesions, 15 were adenocarcinomas many). Hybridization and selective washing steps were performed as described and 40 tubular adenomas mainly characterized by moderate or severe dysplasia (23) . Detection of the digoxigenin labeled oligos was accomplished using or both, although a few mildly dysplastic adenomas were also observed. Two anti-digoxigenin-alkaline phosphatase as conjugate and CSPD (Boehringer out of the 57 tumors were tubulovillous adenomas with moderate and Mannheim, Mannheim, Germany) as substrate, according to the manufacturer's severe dysplasia.
instructions.
Tumor DNA isolation GC-clamped denaturing gradient gel electrophoresis (DGGE) of exons 7 and
Five to ten 25 µm thick paraffin sections were placed on glass slides, 8 of Tp53 deparaffinized, rehydrated and briefly stained with hematoxylin. The area A 242 bp and a 282 bp GC-clamped fragment encompassing Tp53 exons 7 containing the tumor cells was subsequently scraped under a dissection and 8 respectively were obtained in two rounds of amplification. For the microscope using as reference a hemotoxylin and eosin (HE) stained 5 µm second round of amplification nested primers were used, one of which section. DNA was isolated from the scraped material essentially as described contained a 40-bp 5Ј-GC-clamp (5Ј-CGCCCGCCGCGCCCCGCGCCCGelsewhere (20) . Briefly, the isolated neoplastic tissue was transferred in 250 µl TCCCGCCGCCCCCGCCCC-3Ј). The position of the GC-clamped primer extraction buffer (10 mM TrisϪHCl pH 8.0, 100 mM NaCl, 25 mM EDTA, and of the opposing primer were developed based on DNA melting behavior 0.5% SDS, 300 µg/ml Proteinase K) and incubated at 55°C for 40 h. A second simulations performed with the MELT87 program (24) . PCR conditions were aliquot of 60 µg of Proteinase K was added after 20 h of incubation. Cellular as described for the ras mutation analysis, except for 2.5 mM MgCl 2 , an proteins were removed by a phenol/chloroform and chloroform extraction annealing temperature of 60°C, and 2.5% formamide substituting for 10% followed by a 30 min precipitation at Ϫ20°C with 125 µl 7.5 M NH 4 Ac, glycerol in the second round of amplification of exon 8. For each exon a 20 µg glycogen and 625 µl ethanol. The precipitate was suspended in 150 µl positive control with a known mutation was amplified to validate the DGGE TE-4 (10 mM TrisϪHCl pH 8.0, 0.1 mM EDTA).
conditions used. The optimal ranges of denaturant used for DGGE analysis
Loss of heterozygosity (LOH) analysis of the Apc locus
and the primers used for amplification are listed in Table I . DGGE analysis was performed as described elsewhere (25) . Loss of the wild type Apc allele was analysed by amplifying in a single reaction both the wild type and targeted Apc alleles with three primers: a
Immunohistochemistry for Tp53 common forward primer (Apc-A2, 5Ј-TCAGCCATGCCAACAAAGTCA-3Ј)
Immunohistochemical staining with the polyclonal CM5 antibody (kindly and two allele-specific reverse primers (Apc-C2, 5Ј-GGAAAAGTTTATprovided by Dr David Lane) was performed on 5 µm sections according to AGGTGTCCCTTCT-3Ј, and Neo3, 5Ј-CACTTCATTCTCAGTATTGTTTTGthe protocol described by Midgley et al. (26) . As positive controls, sections 3Ј). Amplification from primers Apc-A2 and Apc-C2 results in a 216 bp of UV-B induced skin tumors of hairless mice were used, in which previously product diagnostic of the wild type allele, while the combination Apc-A2 and positive staining and a Tp53 mutation were detected. Neo3 yields a product of 227 bp diagnostic of the targeted Apc1638N allele. A radioactive PCR was performed on 1 µl of tumor DNA or 1 µl normal
Results
DNA samples, the latter isolated from normal intestinal paraffin sections and tail samples from Apc ϩ /Apc1638N mice. Duplicate reactions were performed
General strategy
for each DNA sample. Amplifications were performed in a 10 µl volume, containing 10 mM TrisϪHCl, pH 8.9, 50 mM KCl, 2. (Table II) . No significant loss was seen in the remainder of the tumors, i.e. 17% (n ϭ 6) and 36% (n ϭ 8) of the B6-Apc1638N and C3HxB6-Apc1638N tumors respectively. In total, the CRs were indicative of a loss at the wild type Apc allele in 75% (43 out of 57) of the tumors analysed.
Analysis of chromosome 18 loss
To assess whether the observed loss at the Apc gene extends to be lost, 13 showed LOH at all chromosome 18 markers. In the remaining tumor (no. C14 in Table IIA ) no loss at any of extent of the Apc LOH events on mouse chromosome 18 was the employed markers could be detected. Three tumors for also examined.
which the comparative ratios at the Apc gene were between Tumors were isolated from heterozygous Apc ϩ /Apc1638N 1.3 and 1.5 (tumors no. C15, C16 and C17 in Table IIA) , mice on two different genetic backgrounds: C57BL/6J (B6-showed evidence of LOH at some of the chromosome 18 Apc1638N) and an F1 resulting from a cross between the markers tested, while other markers were again close to the B6-Apc1638N mice and the C3H inbred strain (C3HxB6-significant value of 1.5. In fact, two of these three lesions Apc1638N); the latter were generated to facilitate the loss of were found to be characterized by infiltration of significant chromosome 18 analysis. However, during the analysis of the amounts (Ͼ75%) of normal cells (lymphocytes and stromal C3HxB6-Apc1638N and B6-Apc1638N tumors, it became cells) which might have interfered with the LOH analysis clear that a large number of the markers from the targeted (Figure 2 ). In the remaining five tumors where no Apc LOH chromosome 18 had retained the original 129/Ola alleles from could be detected, both alleles at each chromosome 18 marker the embryonic stem cell line E14, employed for the gene were retained. Again, the latter lesions were characterized by targeting experiments. Nevertheless, we were able to take a significant infiltration of normal cells. advantage of the allelic differences among C3H, B6 and 129/ As mentioned before, during the analysis of the C3HxB6 Ola at several chromosome 18 markers to evaluate the extent tumors, we observed that a high number of tumors had retained of the LOH events.
the 129/Ola alleles at several chromosome 18 markers. This The Apc and Tp53 genes were analysed for loss of heteroenabled us to perform the chromosome 18 LOH analysis on zygosity, while the ras and Tp53 genes were examined for all B6-Apc1638N tumors with dinucleotide repeat markers point mutations by ASO hybridization and DGGE respectively. known to be polymorphic between the 129/Ola and C57BL/ Since, due to technical difficulties, only Tp53 exons 7 and 8 6J inbred strains (Table IIB) . In the 29 tumors where the Apc could be analysed by DGGE, and to exclude the presence of gene was found to be lost, marker D18Mit64, localized 13 cM mutations elsewhere in the gene, sections of the tumors were proximal to Apc, was informative in 26 out of 29 tumors. also analysed by immunohistochemistry.
Marker D18Mit58, localized 10 cM distal to Apc, was inform-
Loss of the wild type Apc allele in Apc1638N tumors
ative in 28 out of 29 tumors. Each of the 25 tumors informative Somatic loss of the wild type Apc allele appears to be an for both markers showed loss of the C57BL/6J alleles obligatory step for adenoma formation in the Min and Apc ∆716 diagnostic of the chromosome containing the wild type Apc models (10) (11) (12) (13) . To determine whether a loss of the remaining allele. No LOH at these markers was observed in the tumors wild type Apc allele also characterizes Apc1638N tumoriwithout a detectable loss of the wild type Apc allele. An genesis, we selectively amplified in a single PCR reaction both example of a LOH analysis with marker D18Mit64 is shown the wild type and targeted Apc allele from tumor DNA samples.
in Figure 3 . Although the number of chromosome 18 markers An example of the Apc LOH analysis of nine tumor samples employed in the latter study is limited, the results clearly and three normal controls is shown in Figure 1 . A significant indicate a similar chromosomal loss as observed in the C3HxB6 tumors. loss of the wild type allele (CR ജ1.5) could be detected in Car  Dysplasia  3  3  3  2 2-3 2-3 2-3 2-3 Contamination ϩϩ ϩϩ ϩϩ ϩ ϩ ϩϩ ϩϩϩ ϩ ϩ ϩϩ ϩϩ ϩ ϩ ϩ ϩϩϩ ϩϩϩ ϩϩϩ 
Ras mutation analysis
Since LOH analysis and screening of exons 7 and 8 alone might result in an underestimation of the involvement of Tp53 Mutational activation of the K-ras gene is a frequently observed in Apc1638N intestinal tumorigenesis, and because point event in human colorectal malignancies and appears to conmutations at this gene often result in the stabilization of the tribute to adenoma progression (7) . We have screened all protein making it detectable by immunohistochemistry, we Apc1638N tumors for the presence of activating mutations at employed the polyclonal CM5 raised against mouse Tp53 for codons 12, 13 and 61 in the murine K-ras homologue by ASO the immunostaining of paraffin embedded Apc1638N tumor hybridization. Surprisingly, no mutation was detected in the sections (26) . No specific staining of tumor cells was detectable 57 tumors examined. To ascertain whether another member of in any of the tumors. These results show that, similar to the the ras family fulfils a similar role in murine intestinal ras genes, mutation of Tp53 is a very infrequent event in tumorigenesis as the K-ras gene in man, a subset of 43 tumors intestinal tumor progression in the Apc1638N mouse model. was analysed for the presence of mutations in H-and N-ras at codons 12, 13 and 61 ( Figure 4) . As in the case of the Discussion K-ras, no mutations were identified at these genes, clearly indicating that ras mutational activation is very rarely associSomatic mutation analysis of the intestinal Apc1638N tumors ated with intestinal tumor progression in the Apc1638N model. has revealed that, as in the case of Min and Apc ∆716 , the Tp53 mutation analysis majority (75%) of the tumors are characterized by a detectable loss of the wild type copy of Apc. This loss appears to extend The Tp53 gene, as is the case of K-ras, is frequently involved in the progression of human intestinal cancer (7) . We employed to the entire chromosome 18, as observed in Min. The results here reported also indicate that 25% (n ϭ 14) of the Apc1638N denaturing gradient gel electrophoresis to detect point mutations in exons 7 and 8 of the murine Tp53 gene. In all tumors analysed did not undergo LOH at the Apc locus. However, it should be said that several of the tumors analysed 57 tumors analysed, no aberrant DGGE patterns indicative of a mutation could be detected. LOH-analysis of the 22 C3HxB6-in the present study (11 out of 14) were characterized by infiltration of the tumor with significant amounts of contaminatApc1638N tumors with markers D11Mit86 and D11Mit320, respectively 11 cM proximal and 5.5 cM distal to Tp53, ing lymphocytes and stromal cells which, upon isolation, may obscure the LOH event. A high number of normal cells in showed no significant loss of the C3H or B6 allele (results not shown).
neoplastic areas is most frequently associated with more advanced stages of tumor progression in Apc1638N (see also absence of LOH in tumors of the Min mouse has also been reported for four out of 32 tumors studied by Laird et al. (13) . Table II ). An illustrative example of lesions with mild and severe contamination of normal cells is shown in Figure 2 .
No mutations of the K-ras, H-ras, N-ras and Tp53 genes were detected in any of the Apc1638N tumors. This result is This high number of normal cells observed in several of the Apc1638N lesions makes it technically more difficult to in contrast with the situation observed in the majority of human colorectal lesions characterized by high frequencies selectively isolate the tumor cells with the method employed here. The detectable loss of Apc in 75% of the Apc1638N of K-ras and TP53 mutations. Several explanations can be envisaged for the virtual absence of ras and Tp53 gene tumors may therefore represent an underestimation of the actual LOH frequency. Nevertheless, in three of the 14 tumors mutations as reported in this study. Although DGGE and ASO-probe hybridization are generally considered sensitive showing no Apc loss, the HE sections used as reference showed no prominent number of normal cells in the neoplastic region techniques (27,28), it is possible that a mutation present in a minority of the cells is not detected. As far as Tp53 is (tumors no. 30, 31, 32 in Table IIB) . Therefore, alternative routes for adenoma formation and progression may exist concerned, analysis of exons 7 and 8 by DGGE and immunohistochemistry will not detect mutations present at other exons independently of a complete Apc inactivation due to large deletions or chromosomal losses, i.e. truncating point mutations not resulting in accumulation of the protein. It appears very unlikely, however, that a more detailed and extensive investior small intragenic deletions and insertions. Interestingly, exposed to a different load of mutagens than the large intestine, a distinct mutation spectrum might be expected. In contrast to the results reported here, analysis of K-ras and TP53 mutations in duodenal tumors from FAP patients, showed that mutations of both genes were detectable (30,31). However, the frequencies of K-ras and especially of TP53 mutations were significantly lower than is generally observed in colonic tumors, a feature that could only partially be explained by the relatively benign histopathological grade of the tumors analysed.
Preliminary data reported by Lipkin et al. (32) , have shown that a significant increase in colonic hyperplasias is observed when Apc1638N animals are fed a 'Western style' diet charac- Tp53 mutations concerns the effect of the loss of the entire chromosome 18 on the cellular phenotype, as previously suggested by Luongo et al. (11) . This chromosomal loss represents a single somatic hit where, along with Apc, one copy of other relevant tumor suppressor genes, i.e. Dcc, Mcc and α-catenin is lost. Given the size of chromosome 18 in mice, it is plausible that other tumor-related genes thus far not identified are involved in the LOH event (33). Haploinsufficiency for one or more of these genes in combination with the absence of the wild type Apc protein could already destabilize the cellular phenotype in such a way that additional hits at Kras or Tp53 would not confer a selective advantage to the existing lesion. However, additional somatic mutations are needed since the Apc1638N tumors clearly show progression from adenomas with mild dysplasia to invasive adenocarcinomas. Investigations are currently in progress to identify such in the Apc1638N mouse is characterized by the somatic loss of the Apc gene as previously described in the Min and Apc ∆716 murine models. More interestingly, adenoma progression in gation of the other exons will result in higher frequencies of Tp53 mutations. mice does not seem to be accompanied by ras or Tp53 mutations in contrast to what has been frequently observed in As far as the K-ras oncogene is concerned, studies on murine lung tumorigenesis have shown that a polymorphism human intestinal tumors. within its second intron is associated with significant differences in the frequencies of K-ras gene mutations among inbred
